At least 40 million women and girls worldwide are affected by female genital schistosomiasis (FGS), a neglected parasitic disease that can cause severe pain and stigma. Yet despite its enormous burden, FGS remains widely overlooked and misdiagnosed.
Treatment options are also limited. Praziquantel, the only available drug, is effective against adult worms but less effective against juvenile worms, highlighting the need for treatments that can target the parasite throughout its life cycle.
Dr Jennifer Downs, from Weill Cornell Medicine and the Weill Bugando School of Medicine in Tanzania, and Dr Amy Sturt, from Stanford University, recently co-led a landmark four-paper series on FGS published in *The Lancet,* bringing together the latest knowledge on its epidemiology, diagnosis, treatment and co-infections.
In this episode, Dr Downs and Dr Sturt take us inside their research, explain why the disease remains so neglected, the pain and stigma experienced by women living with FGS, and why better diagnostics and treatments are urgently needed.
More information on dndi.org/diseases/parasitic-worms/schistosomiasis/
Contact us: [media@dndi.org](mailto:media@dndi.org)
Lancet series on *Schistosomiasis in women and adolescent girls*: www.thelancet.com/series-do/schistosomiasis-in-women-and-adolescent-girls
Introductory music: Maputo Queen by Etienne de la Sayette
Reproduced with the kind permission of the artist
Picture: Brent Stirton/Getty Images for DNDi